Client updates / Companies Law

Increased Enforcement in Pharmaceutical Sector: BMS and Neopharm to Pay ILS Tens of Millions for Delaying Entry of Competing Drug

10 September 2025 / Gal Rozent, Ran Karmi, Yarden Anavi

The Israel Competition Authority (ICA) published a draft consent decree with Bristol-Myers Squibb and Neopharm, requiring payments of over ILS 44 million by the companies and ILS 200,000 by a Neopharm executive, following indications of monopolistic abuse.

See full article >

Categories: Antitrust and Competition

US Scores New Legal Antitrust Victory over Google

7 May 2025 / Irit Brodsky, Ran Karmi

The US government has recorded another big win in the battle that US law enforcement agencies have been waging for years against Google.

See full article >

Categories: Antitrust and Competition

Public Companies without a Controlling Shareholder: Amendment to the Companies Law

27 April 2021 / Michael Barnea

In recent weeks, the Israeli Ministry of Justice published a memorandum proposing an amendment to the Companies Law, focusing on the corporate governance regime in public companies without a controlling shareholder.

See full article >

Categories: Capital Markets | Corporate | Public companies

Ministry of Justice and Israel Securities Authority Wish to Adjust the Israeli Corporate Regime to Companies without a Controlling Shareholder

25 September 2019 / Barnea

The Israel Securities Authority (ISA) and the Ministry of Justice published a call to the public to adjust the corporate regime, as part of addressing problems that may arise as a result of the transition of public companies to a decentralized ownership structure.

See full article >

Categories: Capital Markets | Corporate

Search by Practice

Client updates / Companies Law